Sign in

Private company

ALTEROLA BIOTECH INC.

ALTEROLA BIOTECH INC. is a medicinal chemicals and botanical products company.1 It is headquartered in Birkenhead Merseyside, United Kingdom.1

Last updated Oct 21, 2026.

Overview

-$2.4MNet income, fiscal 20242
  • IndustryMedicinal Chemicals & Botanical Products1
  • HeadquartersBirkenhead Merseyside, United Kingdom1
  • Business address47 Hamilton Square, Birkenhead Merseyside, X0 Ch41 5Ar3
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

FDA, EMA etc.) and used / prescribed by the medical community and any new treatments that may enter the market would face fierce competition.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Revenue56$0 in 2019
02017: $0$020172018: $0$020182019: $0$02019
Operating income567-$258.5K in 2019+426% since 2017
-$300.0K-$200.0K-$100.0K02017: -$49.1K-$49.1K20172018: -$122.6K-$122.6K2018+149%2019: -$258.5K-$258.5K2019+111%
Net income869-$258.7K in 2019+283% since 2017
-$300.0K-$200.0K-$100.0K02017: -$67.6K-$67.6K20172018: -$113.1K-$113.1K2018+67%2019: -$258.7K-$258.7K2019+129%
Fiscal year201720182019
Revenue$05$06$06
Research and development
Operating expenses
Operating income-$49.1K5-$122.6K6-$258.5K7
Interest$18.5K5$10.5K6$2497
Income tax$23.0K5$17.9K12$82.5K7
Net income-$67.6K8-$113.1K6-$258.7K9

Compare ALTEROLA BIOTECH INC. with another company

Corporate structure

ALTEROLA BIOTECH INC. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of ALTEROLA BIOTECH INC.

  • ALTEROLA BIOTECH INC. Birkenhead Merseyside, United Kingdom

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What ALTEROLA BIOTECH INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Inventory

ItemLatestA year beforeChange
Inventory, total$1.0K2 Mar 31, 2024$9902 Mar 31, 2023+1.9%

Former names

  • JEDEDIAH RESOURCES CORP.Dec 12, 2008 to Nov 19, 20103

Timeline

  1. Jun 30, 20258-K Entered a material agreement; Completed an acquisition or sale; Executive or director change14
  2. Sep 30, 20248-K Earlier financial statements no longer reliable15
  3. Sep 12, 20248-K Entered a material agreement; New debt or obligation16
  4. Oct 20, 20238-K Unregistered sale of shares; Change of auditor17
  5. Oct 17, 20238-K Executive or director change18
  6. Sep 19, 20238-K Entered a material agreement19
  7. Jun 22, 20238-K Executive or director change20
  8. Oct 7, 20228-K Entered a material agreement; Executive or director change21
  9. Sep 1, 20228-K Entered a material agreement; Other events22
  10. Jul 7, 20228-K Other events23
  11. May 18, 20228-K Executive or director change; Other events24
  12. May 10, 20228-K Executive or director change25

Filings

59 filings to the SEC since October 2021: 4 annual reports, 12 quarterly reports, 15 major events, 1 insider forms, 2 large holders, 25 other. The latest 20:

  1. Jun 30, 202515-15D EDGAR
  2. Jun 30, 20258-K EDGAR
  3. Feb 14, 2025NT 10-Q EDGAR
  4. Nov 29, 202410-Q EDGAR
  5. Nov 25, 202410-Q/A EDGAR
  6. Nov 14, 2024NT 10-Q EDGAR
  7. Sep 30, 20248-K EDGAR
  8. Sep 12, 20248-K EDGAR
  9. Aug 15, 202410-Q EDGAR
  10. Aug 14, 2024NT 10-Q EDGAR
  11. Jul 18, 202410-K EDGAR
  12. Jun 28, 2024NT 10-K 10-K EXTENSION EDGAR
  13. Feb 21, 202410-Q/A EDGAR
  14. Feb 20, 202410-Q EDGAR
  15. Feb 14, 2024NT 10-Q EDGAR
  16. Nov 21, 202310-Q EDGAR
  17. Nov 14, 2023NT 10-Q EDGAR
  18. Oct 20, 20238-K EDGAR
  19. Oct 17, 20238-K EDGAR
  20. Sep 19, 20238-K EDGAR

The 59 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How ALTEROLA BIOTECH INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARALTEROLA BIOTECH INC.1
  • CIK0001442999
  • Employer ID (EIN)82-13170321
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Fiscal year endsMarch 311
  • Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address47 Hamilton Square, Birkenhead Merseyside, X0 CH41 5AR1
  • Phone44 151 601 94771
  • Shares outstanding1,459,502,018 as of Nov 15, 202411
  • Public float$252.9K as of Sep 30, 20232
  • On EDGAR sinceDec 12, 20081
  • Filings151 in all: 10-Q (48), 8-K (44), 10-K (15), NT 10-Q (13), NT 10-K (5), UPLOAD (5), CORRESP (3), EFFECT (3)1
    All 19 form types

    S-1 (3), 10-Q/A (2), 8-K/A (2), 10-K/A (1), 10-KT (1), 10-KT/A (1), 15-15D (1), 3 (1), 424B3 (1), SC 13D (1), SC 13G (1)

  • Latest filingsAnnual report (10-K) Jul 18, 2024
    Quarterly report (10-Q) Nov 29, 2024
    Latest 8-K (8-K) Jun 30, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
    SEC EDGAROther events
  24. 24
  25. 25
  26. 26
  27. 27